SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 19, 2022
Document Date
Apr 18, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
iTeos Therapeutics
Issuer
ITEOS THERAPEUTICS, INC.
Filer
DETHEUX MICHEL
Cancer Cells graphics

At iTeos we are pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics.

Our differentiated development approach is driven by biologic rationale and clinical need utilizing our IO candidates in intra-portfolio combinations and with programs of external collaborators.

Driven by a culture of scientific innovation, collaboration and excellence, together we discover and deliver breakthrough immunotherapies to improve and extend the lives of people with cancer.